Molecular Therapy

Apply to Be the Next EIC of Molecular Therapy Methods & Clinical Development

Term Begins Jan. 2024 - June 30, 2023

The next editorial leader of MTMCD will assume the role on Jan. 1, 2024.

ASGCT is looking for the next editor-in-chief of Molecular Therapy Methods & Clinical Development (MTMCD) to begin a five-year term on Jan. 1, 2024.

MTMCD is an international, open-access journal publishing important peer-reviewed advances in cell and gene therapy and how they are translated and applied in the clinical setting. Its 2021 impact factor is 5.849. The current editor, Gerhard Bauer, PhD, will step down Dec. 31, 2023.

Read more about the position's responsibilities here. If you're interested in applying, please send a letter of intent detailing your relevant experience and vision for the journal as well as a current CV to ASGCT CEO David Barrett.

Read the position description & Apply

Related Articles

Molecular Therapy

Hear Dr. Maxim Berezovski on the Molecular Therapy Podcast

Listen now! - February 13, 2024
Molecular Therapy

Hear Dr. Richard Vile on the Molecular Therapy Podcast

Listen now! - January 09, 2024
ASGCT News

Mohamed Abou-el-Enein Appointed Editor of Molecular Therapy Methods and Clinical Development

Dr. Abou-el-Enein began five-year term Jan. 1. - January 04, 2024
Molecular Therapy

First Episode of Molecular Therapy Podcast Features Dr. Norbert Pardi

Listen now! - December 12, 2023